 | Related Articles |
Update on treatment of COVID-19: ongoing studies between promising and disappointing results.
Infez Med. 2020 Ahead of print Jun 1;28(2):198-211
Authors: Esposito S, Noviello S, Pagliano P
Abstract
The COVID-19 pandemic represents the greatest global public health crisis since the pandemic influenza outbreak of 1918. We are facing a new virus, so several antiviral agents previously used to treat other coronavirus infections such as SARS and MERS are being considered as the first potential candidates to treat COVID-19. Thus, several agents have been used by the beginning of the current outbreak in China first and all over the word successively, as reported in several different guidelines and therapeutic recommendations. At the same time, a great number of clinical trials have been launched to investigate the potential efficacy therapies for COVID-19 highlighting the urgent need to get as quickly as possible high-quality evidence. Through PubMed, we explored the relevant articles published on treatment of COVID-19 and on trials ongoing up to April 15, 2020.
PMID: 32335561 [PubMed - indexed for MEDLINE]